CapsoVision (CV) Net Equity Issued and Repurchased (2024 - 2025)
CapsoVision (CV) posted Net Equity Issued and Repurchased of -$202000.0 for Q3 2025, down 104.04% sequentially from $5.0 million in Q4 2024, and down 102.03% YoY from $9.9 million in Q3 2024.
CapsoVision (CV) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
CapsoVision has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at -$202000.0 in Q3 2025.
- Quarterly Net Equity Issued and Repurchased fell 102.03% year-over-year to -$202000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $14.7 million (changed N/A YoY) and the FY2024 annual result came in at $15.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased slipped to -$202000.0 in Q3 2025 per CV's latest filing, from $5.0 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $9.9 million in Q3 2024 and troughed at -$202000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | CapsoVision | 299.87 Mn | 290.80 Mn | 1.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -202,000.00 |
| Sep 30, 2025 | -202,000.00 |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 9.93 Mn |
| Sep 30, 2024 | 9.93 Mn |